Mario Cocorullo
Overview
Explore the profile of Mario Cocorullo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cazzaniga G, Mori M, Griego A, Scarpa E, Moschetti G, Muzzioli S, et al.
J Med Chem
. 2025 Mar;
68(5):5312-5332.
PMID: 40029993
The urgent need for safer and innovative antitubercular agents remains a priority for the scientific community. In pursuit of this goal, we designed and evaluated novel 5-phenylfuran-2-carboxylic acid derivatives targeting...
2.
Cocorullo M, Stelitano G, Chiarelli L
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125890
Patients with cystic fibrosis (CF) are prone to developing life-threatening lung infections with a variety of pathogens that are difficult to eradicate, such as , , (), , and ....
3.
Mori M, Cocorullo M, Tresoldi A, Cazzaniga G, Gelain A, Stelitano G, et al.
Eur J Med Chem
. 2024 Jan;
265:116073.
PMID: 38169270
Blocking iron uptake and metabolism has been emerging as a promising therapeutic strategy for the development of novel antimicrobial compounds. Like all mycobacteria, M. abscessus (Mab) has evolved several countermeasures...
4.
Wu X, Wang W, Stelitano G, Riabova O, Wang B, Niu W, et al.
Eur J Med Chem
. 2023 Dec;
264:115976.
PMID: 38039794
A series of novel benzothiozinone (BTZ) derivatives were designed, prepared and evaluated for antituberculosis activity. Specifically, the BTZ pharmacophore is retained and the previous heterocyclic ring linker is replaced by...
5.
Cocorullo M, Chiarelli L, Stelitano G
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37515037
Reverse vaccinology is a powerful tool that was recently used to develop vaccines starting from a pathogen genome. Some bacterial infections have the necessity to be prevented then treated. For...
6.
Stelitano G, Cocorullo M, Mori M, Villa S, Meneghetti F, Chiarelli L
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047161
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections is one of the most crucial challenges currently faced by the scientific community. Developments in the fundamental understanding of their...
7.
Mori M, Stelitano G, Cazzaniga G, Gelain A, Tresoldi A, Cocorullo M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839823
Targeting pathogenic mechanisms, rather than essential processes, represents a very attractive approach for the development of new antimycobacterial drugs. In this context, iron acquisition routes have recently emerged as potentially...